Yoni Bard

1 month ago | mondaq.com | David Lazarus |Yoni Bard

Courts continue to reject aggressive Anti-Kickback Statute("AKS") allegations. Most recently, on January 6, 2025,Judge Patti Saris of the U.S. District Court for the District ofMassachusetts dismissed a qui tam action against clinicallaboratory MD Spine Solutions LLC ("MD Labs") and itsowners, Denis Grizelj and Matthew Rutledge, based in part on lackof causation. Omni Healthcare, Inc. v. MD Spine SolutionsLLC, No. 18-cv-12558-PBS, 2025 U.S. Dist. LEXIS 1680 (D. Mass. Jan. 6, 2025).

1 month ago | mondaq.com | Caroline Donovan |David Lazarus |Yoni Bard |Jasmine Brown

We kick off our annual Year in Preview series with acomprehensive look at health care fraud enforcement in 2025. Thispost proceeds in three parts. First, we explore what the secondTrump administration might bring, looking at enforcement metricsfrom Trump's first presidency while examining the priorities wemight expect from the current nominees to key health care agencies.

1 month ago | mondaq.com | Caroline Donovan |David Lazarus |Yoni Bard

This is the sixth in our 2025 Year in Preview seriesexamining important trends in white collar law and investigationsin the coming year. We will be posting further installments in theseries throughout the next several weeks. Our previous post,"Year in Preview: Review of and Insights into Investigationsby the 119th Congress" can be found here. The Attorney General and key Department of Justice leadershipare now in place and appear to have hit the ground running.

Jan 8, 2025 | jdsupra.com | Yoni Bard |David Lazarus

Courts continue to reject aggressive Anti-Kickback Statute (“AKS”) allegations. Most recently, on January 6, 2025, Judge Patti Saris of the U.S. District Court for the District of Massachusetts dismissed a qui tam action against clinical laboratory MD Spine Solutions LLC (“MD Labs”) and its owners, Denis Grizelj and Matthew Rutledge, based in part on lack of causation. Omni Healthcare, Inc. v. MD Spine Solutions LLC, No. 18-cv-12558-PBS, 2025 U.S. Dist. LEXIS 1680 (D. Mass. Jan. 6, 2025).

Apr 15, 2024 | mondaq.com | Alison Bauer |Yoni Bard

In a March 2024 decision, the U.S. Bankruptcy Appellate Panel for the First Circuit (the "Panel") followed existing case law prohibiting debtors in businesses related to cannabis from availing themselves of federal bankruptcy protections. The Panel, however, declined to follow a bright-line rule categorically denying bankruptcy relief to employees of cannabis businesses.